Takeda

Mergers & Acquisitions Celltrion to sell portfolio of Takeda drugs to CBC Group

South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...

Bio & Pharma Celltrion puts Takeda’s assets up for sale after 3 years

South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...

Bio & Pharma S.Korea, Japan compete in gastroesophageal reflux drug market

South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...

Mergers & Acquisitions Celltrion finalizes $278mn acquisition of Takeda's primary care assets

South Korea's biopharmaceutical firm Celltrion Inc. has completed the $278 million acquisition of Takeda Pharmaceutical Company Ltd's primary care a...